Skip to content

13F-HR filed by DSC Advisors, L.P.

DSC Advisors, L.P. filed this 13F-HR for the quarter ended 2022-12-31, filed 2023-02-14, with 15 holding rows worth $43,507,788.

Accession
0001315863-23-000335
Filed
2023-02-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2022

A holdings report, 17 entries on the cover page, a total value of $43,507,788 stated on the cover page (in dollars after the unit check, H1), rows summing to $43,507,788 with VALUE read as dollars as filed, 13F file number 028-11157. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
R1 RCM INC77634L105COM1,000,000$10,950,000dollars as filed
CVS Health Corporation126650100COM98,797$9,206,892dollars as filed
BIOMARIN PHARMACEUTICAL INC09061G101COM82,500$8,537,925dollars as filed
ZIMMER BIOMET HOLDINGS INC COM98956P102Stock62,530$7,972,575dollars as filed
Alphabet Inc. Reg. Shares C02079K107COM46,000$4,081,580dollars as filed
EHEALTH INC28238P109COM75,000$363,000dollars as filed
Microsoft Corp594918104COM1,486$356,373dollars as filed
Alphabet Inc. Reg. Shares A02079K305COM3,753$331,127dollars as filed
Visa Inc92826C839COM1,354$281,307dollars as filed
META PLATFORMS INC CL A30303M102COM2,262$272,209dollars as filed
MasterCard, Inc57636Q104COM779$270,882dollars as filed
VYNE THERAP.92941V209COM1,570,000$235,500dollars as filed
Apple Inc037833100COM1,778$231,016dollars as filed
Accenture Plc Class AG1151C101COM784$209,203dollars as filed
Berkshire Hathaway Inc084670702COM674$208,199dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001315863-23-000335this filing2023-02-14acceptance time not in the bulk data set